RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTIT…

[ad_1]
RT @OphthTimes: . @REGENXBIO announces dosing of first patient in phase II ALTITUDEā„¢ trial of RGX-314 for the diabetic retinopathy treatmenā€¦
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.